Our Members

As a member-focused Association, our members are at the heart of everything we do at the PRI.

In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.

Find out more about the different ways you and your organization can get involved with the PRI’s activities.

  • Microbiome Regulatory Science Support Work
  • Pre-competitive Task Groups
  • Year-round networking and project-related communication support

More than 100 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.

Seventure Partners

Seventure Partners

Isabelle de Cremoux

CEO & Managing Partner

Seventure Partners finances the development of innovative companies within Life sciences and Digital technologies. We have 20 years of experience which has enabled Seventure to acquire expertise and networks in these two fields which services the needs of entrepreneurs.

 

SGS Quay Pharma

SGS Quay Pharma

Michael Kruidenier

Head of BD

No other CDMO has the breadth of knowledge in the formulation services we offer, our clinical trials manufacturing and supply know how as well as our specialist knowledge in providing cost efficient engineering solutions to meet the many challenges that we know can accompany the finished product manufacture of microbial therapies.

 

Siolta Therapeutics

Siolta Therapeutics

Nikole Kimes

CEO & Founder

Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based medicines.

 

SkinBiotherapeutics PLC

SkinBiotherapeutics PLC

Stephen France

R&D | Innovation

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

 

SMALTIS

SMALTIS

Cédric MULLER

CEO

Smaltis is a laboratory specialized in microbiology, delivering tailor-made solutions to support the development of health products, in the fields of antimicrobials, microbiota and bioproduction projects.

 

Spanish National Research Council (IATA-CSIC)

Spanish National Research Council (IATA-CSIC)

Yolanda Sanz

Full Professor

Microbiome, Intestinal Human Bacteria, Immunity, Body-Brain Interactions, Diet, Obesity, Diabetes, Cardiovascular Disease, Mood, Comorbidities, Microbiome-Based Diagnosis, Prevention and Therapy, Microbiome-Directed Nutrition.

 

Synlogic, Inc.

Synlogic, Inc.

Ann Taylor

CMO

Synlogic is working at the intersection of biology and engineering, pioneering the application of synthetic biology to design living therapeutics programmed to treat disease in new ways.

 

Takeda

Takeda

Scott Butler

Global Program Leader

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society.